Takeda has committed JPY 4.6 billion (roughly US$32 million) to five new global Corporate Social Responsibility (CSR) partnerships. This is part of the company’s ongoing efforts to strengthen the resilience of healthcare systems in low- and middle-income nations worldwide.
Through this commitment, Takeda is demonstrating its commitment to addressing systemic disparities and empowering local leadership in order to improve access to and the delivery of equitable and sustainable healthcare. It also aims to strengthen healthcare infrastructure, empower the workforce, and increase local knowledge and capacity.
Takeda’s influence is anticipated to reach 27 million people in 93 countries by 2030. Since the program’s launch in 2016, Takeda has contributed more than JPY 28.8 billion (roughly US$ 199.1 million) through 34 major partnerships. In a poll conducted by all Takeda employees, over 22,000 workers from 80 different countries and regions chose the five new partners, underscoring Takeda’s dedication to an inclusive and cooperative approach to its global corporate giving program.
Read also – [Funding news] Genesis Alternative Ventures Raises US$125 Million for Second Venture Debt Fund
Their 13.4 million people had better access to, coverage of, and quality of care (such as screening, referrals, and follow-ups); Their 28,000 people received necessary medical supplies; Their 4.1 million community members received targeted health education on topics like nutrition, water, sanitation, hygiene, and sexual and reproductive health; and over 2,700 health facilities were built or renovated.
Together with their partners, they hope to enhance the patient’s experience and advance toward a new frontier of treatment options through their dynamic and diverse pipeline. As a leading biopharmaceutical company with a focus on research and development and a basis in Japan, they are guided by their commitment to patients, themselves, and the environment.
Takeda has centered its business decisions around patients, people, and society ever since its founding in 1781. We are dedicated to being a reputable partner that helps society tackle global health issues. Since2016, our Global CSR Program has provided a compelling illustration of our dedication,” said Takako Ohyabu, Takeda’s Global Head of Corporate Affairs and Sustainability. “As the cornerstones of a resilient health system, equity, scalability, and sustainability are something I am very pleased of in each of our new partners. These long-term collaborations need to improve health outcomes and spur innovation for people worldwide, particularly for marginalized groups living in remote and conflict-affected areas. They also need to share priceless insights and have a noticeable impact.
About Takeda
Takeda is committed to fostering global prosperity and improved human health. Their goal is to find and provide treatments that change people’s lives in all of their therapeutic and business areas, which include immunology, oncology, rare illnesses, gastrointestinal and inflammatory disorders, plasma-derived therapeutics, and neuroscience.
